Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

It has traditionally been thought that in mammals only mothers are able to influence the sex of their offspring.

Image courtesy of Shutterstock

But a new study in wild mice led by Dr Aurelio Malo of Oxford University's Department of Zoology has shown that fathers can, in fact, influence sex ratios.

The paper is published in the journal Proceedings of the Royal Society B and involves researchers from the UK, Spain and the USA.

Dr Malo said: 'In mammals, theory predicts that offspring sex ratios can only be determined by the mother, as fathers have always been thought to inseminate an equal proportion of X and Y sperm, having a random effect on offspring sex that they could not shift from equality, or 50:50.

'Also, mothers can influence their offspring in a number of ways from copulation to birth, whereas fathers have control over sperm only. This gives mothers more scope to alter the sex ratio of their offspring. The physical costs of gestation are obviously higher for the mother, so it's in her own interests from an evolutionary point of view to invest her resources wisely in terms of the sex, size and quality of her offspring.

Read more....

Similar stories

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

Clinical Trials Coronavirus COVID-19 General Research

The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.

Ancient gene mutation found to cause rare hereditary condition

General Research

UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).